Neurodevelopmental Outcomes in Preterm Infants with White Matter Injury Using a New MRI Classification

• Published in: Neonatology (Basel, Switzerland) p. 1
• Main Authors: Martinez-Biarge, Miriam, Groenendaal, Floris, Kersbergen, Karina J, Benders, Manon J N L, Foti, Francesca, van Haastert, Ingrid C, Cowan, Frances M, de Vries, Linda S
• Format: Journal Article
• Language: English
• Published: Switzerland 01.10.2019
• Subjects: White matter injury; Preterm infant; MRI; Outcome
• ISSN: 1661-7819
• DOI: 10.1159/000499346

The aim of this study was to evaluate whether a new MRI scoring system for preterm non-haemorrhagic white matter injury (WMI), derived from the analysis of the natural evolution of WMI throughout the neonatal period until term-equivalent age, can be used for outcome prediction. Eighty-two infants <36 weeks gestation with WMI diagnosed from sequential cranial ultrasound and confirmed on neonatal MRI were retrospectively included. WMI was classified in four grades of severity. Neurodevelopmental data at a median age of 24 months were analysed. In 74 surviving children WMI severity was strongly associated with the presence and severity of cerebral palsy (CP) and other neurodevelopmental impairments (Spearman's rank correlation 0.88, p < 0.001). Only 3 children with grade I WMI (9%) developed CP (all ambulant) and their developmental scores were not different to those from the controls, although they started walking significantly later (p = 0.036). Of the 6 children with grade II, 83% developed CP (mild in most), whereas 91% of the 34 children with grade III had CP (moderate-severe in 76%) and all had some degree of neurodevelopmental impairment. Three children with grade III WMI did not develop CP; their imaging showed, in contrast to children who developed CP, that the cysts did not affect the corticospinal tracts; also, myelin in the posterior limb of the internal capsule appeared normal in 2 children and suboptimal in 1. This MRI scoring system for preterm WMI can be used to predict neurodevelopmental outcomes. Individualized assessment of the site of lesions and the progression of myelination improves prognostic accuracy.